The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Alignment Healthcare Inc (NASDAQ: ALHC) closed at $15.53 down -7.39% from its previous closing price of $16.77. In other words, the price has decreased by -$7.39 from its previous closing price. On the day, 13.03 million shares were traded. ALHC stock price reached its highest trading level at $17.1954 during the session, while it also had its lowest trading level at $14.1.
Ratios:
For a deeper understanding of Alignment Healthcare Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 3.05 whereas as Long-Term Debt/Eq ratio is at 3.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 01 ’25 when JOYCE CHRISTOPHER J sold 25,000 shares for $16.87 per share. The transaction valued at 421,828 led to the insider holds 390,022 shares of the business.
CHRISTOPHER JOYCE bought 40,491 shares of ALHC for $717,501 on May 01 ’25. On Apr 14 ’25, another insider, Maroney Dawn Christine, who serves as the President of the company, sold 230,000 shares for $19.10 each. As a result, the insider received 4,392,195 and left with 2,132,899 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3072501760 and an Enterprise Value of 2923330304. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.02 while its Price-to-Book (P/B) ratio in mrq is 28.39. Its current Enterprise Value per Revenue stands at 0.974 whereas that against EBITDA is -86.196.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.31, which has changed by 1.2905605 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $5.16. The 50-Day Moving Average of the stock is -8.43%, while the 200-Day Moving Average is calculated to be 20.64%.
Shares Statistics:
For the past three months, ALHC has traded an average of 3.02M shares per day and 4301610 over the past ten days. A total of 197.67M shares are outstanding, with a floating share count of 109.98M. Insiders hold about 44.36% of the company’s shares, while institutions hold 56.17% stake in the company. Shares short for ALHC as of 1744675200 were 10482265 with a Short Ratio of 3.47, compared to 1741910400 on 8266768. Therefore, it implies a Short% of Shares Outstanding of 10482265 and a Short% of Float of 8.140001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
